Crime
One terrorist killed as Army repels attack on base in Kaduna
Troops of the Nigerian Army on Sunday repelled an attack on its base in Kankomi, Chikun LGA, in Kaduna state by terrorists, killing one of the attackers in the process.
According to the feedback given to the Kaduna State Government, the attackers made an attempt to infiltrate the location housing the troops.
The vigilant troops in response engaged them in a fierce gun duel that lasted for over an hour. This resulted in the elimination of one of the terrorists, who was wearing military camouflage combat gear.
Others escaped with bullet wounds as evidenced by bloodstains along their withdrawal route.
The troops recovered one AK-47 rifle, seven AK47 magazines, seven rounds of ammunition, and five locally made grenades from the terrorists.
Sadly, while exploiting the withdrawal route, soldiers discovered that the terrorists killed three locals in their attempt to escape.
The Governor of Kaduna State, Malam Nasir El-Rufai, however, received the feedback with sadness.
He sent his deepest condolences to the families of the victims and prayed for the repose of their souls. The Governor expressed gratitude to the courageous troops for their resilient efforts and dedication.
Meanwhile, citizens in the area are advised not to harbor or provide support to suspicious persons seeking medical attention for gunshot injuries.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business6 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics7 days agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured7 days agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health3 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

